Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin

被引:23
作者
Bayry, J [1 ]
Lacroix-Desmazes, S
Hermine, O
Oksenhendler, E
Kazatchkine, MD
Kaveri, SV
机构
[1] INSERM, U681, Paris, France
[2] Univ Paris 06, Inst Cordeliers, Paris, France
[3] Edward Jenner Inst Vaccine Res, Compton, Berks, England
[4] Hop Necker Enfants Malad, Dept Hematol, Paris, France
[5] Hop Necker Enfants Malad, CNRS, UMR 8603, Paris, France
[6] Hop St Louis, Dept Clin Immunopathol, Paris, France
关键词
D O I
10.1016/j.amjmed.2005.06.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1439 / 1440
页数:2
相关论文
共 10 条
[1]   Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-α present in serum from patients with systemic lupus erythematosus [J].
Bayry, J ;
Lacroix-Desmazes, S ;
Delignat, S ;
Mouthon, L ;
Weill, B ;
Kazatchkine, MD ;
Kaveri, SV .
ARTHRITIS AND RHEUMATISM, 2003, 48 (12) :3497-3502
[2]   Common variable immunodeficiency is associated with defective functions of dendritic cells [J].
Bayry, J ;
Lacroix-Desmazes, S ;
Kazatchkine, MD ;
Galicier, L ;
Lepelletier, Y ;
Webster, D ;
Lévy, Y ;
Eibl, MM ;
Oksenhendler, E ;
Hermine, O ;
Kaveri, SV .
BLOOD, 2004, 104 (08) :2441-2443
[3]   Natural antibodies sustain differentiation and maturation of human dendritic cells [J].
Bayry, J ;
Lacroix-Desmazes, S ;
Donkova-Petrini, V ;
Carbonneil, C ;
Misra, N ;
Lepelletier, Y ;
Delignat, S ;
Varambally, S ;
Oksenhendler, E ;
Lévy, Y ;
Debré, M ;
Kazatchkine, MD ;
Hermine, O ;
Kaveri, SV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (39) :14210-14215
[4]   Common variable immunodeficiency: Clinical and immunological features of 248 patients [J].
Cunningham-Rundles, C ;
Bodian, C .
CLINICAL IMMUNOLOGY, 1999, 92 (01) :34-48
[5]   Intravenous immunoglobulin in autoimmune neuromuscular diseases [J].
Dalakas, MC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (19) :2367-2375
[6]   Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency [J].
de Gracia, J ;
Vendrell, M ;
Alvarez, A ;
Pallisa, E ;
Rodrigo, MJ ;
de la Rosa, D ;
Mata, F ;
Andreu, J ;
Morell, F .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2004, 4 (06) :745-753
[7]   Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. [J].
Kazatchkine, MD ;
Kaveri, SV .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) :747-755
[8]   Cutaneous granulomatous lesions in common variable immunodeficiency: Complete resolution after intravenous immunoglobulins [J].
Pujol, RM ;
Nadal, C ;
Taberner, R ;
Diaz, C ;
Miralles, J ;
Alomar, A .
DERMATOLOGY, 1999, 198 (02) :156-158
[9]   MEDICAL PROGRESS - THE PRIMARY IMMUNODEFICIENCIES [J].
ROSEN, FS ;
COOPER, MD ;
WEDGWOOD, RJP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (07) :431-440
[10]   Monocyte derived dendritic cell responses in common variable immunodeficiency [J].
Scott-Taylor, TH ;
Green, MRJ ;
Eren, E ;
Webster, ADB .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (03) :484-490